Today: 7 February 2026
Subscribe
Browse Category

Stock Market News 12 January 2026

FTSE 100 slips as Barclays takes a hit from Trump’s credit-card cap push; gold miners climb

FTSE 100 slips as Barclays takes a hit from Trump’s credit-card cap push; gold miners climb

Barclays dropped 4% after U.S. President Trump called for a 10% cap on credit-card interest rates, weighing on UK stocks. The FTSE 100 slipped 0.1% by 0823 GMT, while sterling rose 0.3% to about $1.34. Miners gained as gold hit a record $4,563.61 an ounce. HSBC and other European banks also fell on concerns over U.S. policy risks.
12 January 2026
······
Valens Semiconductor stock dips in premarket after 59% spike; VA7000 ADAS win still in focus

Valens Semiconductor stock dips in premarket after 59% spike; VA7000 ADAS win still in focus

Valens Semiconductor shares fell 4.4% to $2.37 in premarket trading Monday, retracing part of Friday’s 59% surge after news of a new automotive design win. The company expects production tied to the win to start in 2027. Options activity shows a bullish tilt, while analysts tracked by MarketScreener average a $3.75 price target. Valens last reported a $7.3 million quarterly net loss with $93.5 million in cash and no debt.
12 January 2026
·
Hims & Hers Health (HIMS) stock slides premarket after Amazon’s Wegovy pill move — what traders watch next

Hims & Hers Health (HIMS) stock slides premarket after Amazon’s Wegovy pill move — what traders watch next

Hims & Hers shares fell 2.2% to $31.00 in premarket trading Monday after a 6.4% drop Friday. The decline followed Amazon Pharmacy’s move to offer Novo Nordisk’s Wegovy weight-loss pill nationwide, intensifying competition in the online obesity drug market. Investors are watching Hims’ upcoming earnings for signs of pressure on its GLP-1 business and marketing costs.
12 January 2026
·
Pan American Silver PAAS stock jumps in premarket as silver smashes records — what to watch next

Pan American Silver PAAS stock jumps in premarket as silver smashes records — what to watch next

Pan American Silver shares jumped 4.5% to $56.70 in U.S. premarket trading Monday as silver futures surged 6% on CME. The rally followed news of a criminal probe involving Fed Chair Jerome Powell, sparking investor demand for hard assets. Other silver miners and the Global X Silver Miners ETF also climbed. Pan American’s next earnings are due Feb. 18.
12 January 2026
··
Tempus AI stock jumps in premarket after $1.27 billion revenue preview, contract value tops $1.1 billion

Tempus AI stock jumps in premarket after $1.27 billion revenue preview, contract value tops $1.1 billion

Tempus AI shares rose about 11% in premarket trading Monday after the company reported preliminary 2025 revenue of $1.27 billion, up 83% year-on-year, and record contract value exceeding $1.1 billion. The company cited strong growth in both Diagnostics and Data segments, with over 70 new data agreements signed in 2025. Tempus noted the results are unaudited and subject to change.
12 January 2026
·······
NovaBay Pharmaceuticals (NBY) stock slides premarket after 102% surge — dilution risk back on radar

NovaBay Pharmaceuticals (NBY) stock slides premarket after 102% surge — dilution risk back on radar

NovaBay Pharmaceuticals shares fell 10% to $17.21 in premarket trading Monday, following a 102.5% surge Friday on unusually heavy volume. Traders are watching for updates on warrants and share supply after the company disclosed possible new share issuances and a reverse split. NovaBay has not commented on the recent volatility. Fourth-quarter results are expected March 25.
12 January 2026
··
IREN Limited stock (NASDAQ: IREN) nudges up premarket as bitcoin steadies and CPI looms

IREN Limited stock (NASDAQ: IREN) nudges up premarket as bitcoin steadies and CPI looms

IREN shares rose 0.7% to $46.03 in early premarket trading Monday. Bitcoin hovered near $90,700, while crypto-mining stocks showed mixed moves. Investors await Tuesday’s U.S. CPI report and IREN’s earnings, expected Feb. 11. Microsoft’s $9.7 billion deal with IREN remains in focus, with contract terms tied to delivery deadlines.
12 January 2026
····
Oklo stock jumps again in premarket as Meta nuclear deal keeps OKLO in focus

Oklo stock jumps again in premarket as Meta nuclear deal keeps OKLO in focus

Oklo shares rose 7.9% to $105.31 in early premarket trading Monday after Meta announced 20-year nuclear power deals, including a collaboration with Oklo on small modular reactors. Oklo confirmed Meta will prepay for power and help fund a 1.2-gigawatt project in Ohio. Vistra and NuScale Power also gained before the bell. Regulatory hurdles and insider selling remain in focus.
12 January 2026
····
Standard Chartered PLC stock slips after buyback update as green bond demand comes into focus

Standard Chartered PLC stock slips after buyback update as green bond demand comes into focus

Standard Chartered shares fell 0.1% to 1,793.5 pence in early London trading after the bank announced it repurchased and will cancel 548,950 shares at an average price of 1,795.91 pence. The lender also completed its first €1 billion green bond, drawing over €3.9 billion in orders. Investors await further updates on capital returns and funding costs ahead of full-year results on Feb. 24.
12 January 2026
·
Imperial Brands share price today: IMB ticks up as buyback keeps running and dividend dates near

Imperial Brands share price today: IMB ticks up as buyback keeps running and dividend dates near

Imperial Brands shares rose about 0.5% in early London trading Monday after the company disclosed new share repurchases under its £1.45 billion buyback program. The stock traded at 3,027 pence at 0914 GMT. Investors are watching the Jan. 28 AGM and the ex-dividend date in February. Abbe Luersman joins the board as non-executive director starting Jan. 12.
12 January 2026
····
Lloyds share price dips as Trump’s credit-card cap rattles bank stocks

Lloyds share price dips as Trump’s credit-card cap rattles bank stocks

Lloyds Banking Group shares fell 0.2% to 100.1 pence in early London trading Monday, tracking a wider decline in European bank stocks after the U.S. announced a cap on credit-card interest rates. Barclays dropped 4.5%, HSBC slipped 1%. Lloyds will report preliminary 2025 results on Jan. 29. The bank is also considering raising CEO Charlie Nunn’s maximum pay to £13.2 million, per The Guardian.
12 January 2026
·
3i Group stock slips again in London as Jan 29 update nears

3i Group stock slips again in London as Jan 29 update nears

3i Group shares fell 0.7% to 3,101 pence by 0942 GMT, extending recent losses as investors await the company’s Q3 update on Jan. 29. The stock trades at an 11% premium to net asset value but remains 31% below its 52-week high. European markets slipped after U.S. policy news hit banks and dampened risk appetite.
12 January 2026
·
British American Tobacco shares rise on buyback update — what to watch before Feb. 12 results

British American Tobacco shares rise on buyback update — what to watch before Feb. 12 results

British American Tobacco shares rose 1.2% to 4,110p in early London trading Monday after announcing more share buybacks. On Jan. 9, BAT bought 132,817 shares at an average 4,015p each, planning to cancel them and reduce the share count to 2.18 billion. The buyback program is now set at £1.3 billion for 2026. Full-year 2025 results are due Feb. 12.
12 January 2026
··
Prudential plc shares slip after buyback update; what investors watch next

Prudential plc shares slip after buyback update; what investors watch next

Prudential (PRU.L) repurchased 330,946 shares on Jan. 9 as part of its new $1.2 billion buyback program. The stock slipped about 0.3% to 1,157 pence in early London trading Monday. Shares were acquired via J.P. Morgan Securities at an average £11.5684 each and will be cancelled, reducing the share count to about 2.55 billion. Traders are watching buyback pace and upcoming Bank of England rate decisions.
12 January 2026
··
1 … 375 376 377 378 379 … 1,170

Stock Market Today

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
New York, Feb 7, 2026, 11:29 ET — Market closed. AbbVie shares closed up 2% on Friday at $223.43, extending a second straight session of gains as U.S. stocks rallied. The stock is still roughly 9% below its 52-week high, and trading volume ran a bit under its recent average. (MarketWatch) The bounce comes as investors work through AbbVie’s post-earnings reset and what it means for 2026. The drugmaker said fourth-quarter net revenues rose 10% to $16.618 billion and adjusted profit per share—excluding certain items—was $2.71; it forecast 2026 adjusted earnings of $14.37 to $14.57 a share. Chief Executive Robert
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

7 February 2026
Bank of America shares rose 2.89% Friday to $56.53, tracking a rally in U.S. financial stocks as the Dow closed above 50,000. The bank will redeem its Series DD preferred stock and related depositary shares on March 10 at $1,000 per share. CEO Brian Moynihan donated 100,000 shares on Feb. 4, a regulatory filing showed. Key U.S. jobs and inflation data are due next week after delays.
Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

7 February 2026
Oracle shares jumped 4.65% to $142.82 Friday, ending an eight-day slide but remaining down 22% since Jan. 27. The company has set up a $20 billion at-the-market stock program and completed a $25 billion senior notes sale to fund cloud expansion. Oracle’s liabilities stood at $174.5 billion as of Nov. 30, 2025, before the new financing. Investors remain focused on dilution risks and the pace of capacity growth.
Go toTop